Year archive

RADIOPHARM THERANOSTICS LIMITED — 2022 filings

All 112 regulatory filings released by RADIOPHARM THERANOSTICS LIMITED (RAD) in 2022, sourced directly from the official regulator.

112 Filings

2022 Period

2022 filings (112)

Filing	Released	Lang
aVb6 Integrin (RAD301) IND approval for Phase 1 trial 2 pages 145.4KB Regulatory Filings	2022-12-29	English
RAD201 HER2 nanobody demonstrates favourable tumor targeting 2 pages 136.8KB Regulatory Filings	2022-12-12	English
Change of Director's Interest Notice - HL 3 pages 181.4KB Regulatory Filings	2022-12-08	English
Change of Director's Interest Notice - LA 3 pages 180.8KB Regulatory Filings	2022-12-08	English
Change of Director's Interest Notice - IT 3 pages 181.6KB Regulatory Filings	2022-12-08	English
Change of Director's Interest Notice - RC 3 pages 182.1KB Regulatory Filings	2022-12-08	English
Change of Director's Interest Notice - PH 3 pages 182.1KB Regulatory Filings	2022-12-08	English
Change in substantial holding - PH 3 pages 227.7KB Regulatory Filings	2022-12-08	English
Notification regarding unquoted securities - RAD 8 pages 35.0KB Regulatory Filings	2022-12-05	English
Change of Director's Interest Notice - MB 3 pages 198.5KB Regulatory Filings	2022-12-01	English
Change of Director's Interest Notice - IT 3 pages 199.2KB Regulatory Filings	2022-11-30	English
Change of Director's Interest Notice - PH 3 pages 180.6KB Regulatory Filings	2022-11-28	English
Change of Director's Interest Notice - RC 3 pages 180.7KB Regulatory Filings	2022-11-28	English
Security Class Reinstatement to Quotation 1 page 90 Regulatory Filings	2022-11-27	English
Appendix 2A 21 pages 389.5KB Regulatory Filings	2022-11-24	English
Top Holders Report RADO Options 2 pages 72.0KB Regulatory Filings	2022-11-24	English
Application for quotation of securities - RAD 6 pages 28.5KB Regulatory Filings	2022-11-24	English
Notice Under Section 708A 1 page 129.0KB Regulatory Filings	2022-11-24	English
Additional data released from brain metastases imaging trial 3 pages 919.1KB Regulatory Filings	2022-11-22	English
RAD agreement with ANSTO to supply key isotope lutetium-177 2 pages 161.9KB Regulatory Filings	2022-11-21	English
Successful completion of Retail Entitlement Offer 2 pages 143.9KB Regulatory Filings	2022-11-21	English
Security Class Suspension from Quotation RADO 1 pag Regulatory Filings	2022-11-20	English
Application for quotation of securities - RAD 6 pages 27.3KB Regulatory Filings	2022-11-17	English
AGM Presentation 16 pages 1.2MB Regulatory Filings	2022-11-15	English
Results of Annual General Meeting 3 pages 568.1KB Regulatory Filings	2022-11-15	English
Entitlement Offer - Extension of Retail Offer 1 pag Regulatory Filings	2022-11-07	English
Update - Proposed issue of securities 54 pages 722.1KB Regulatory Filings	2022-11-07	English
Notification of Release of Shares from Escrow 1 pag Regulatory Filings	2022-11-07	English
AGM ATTENDANCE 1 page 150.7KB Regulatory Filings	2022-11-07	English
Change of Director's Interest Notice - RC 3 pages 211.6KB Regulatory Filings	2022-10-30	English
Change of Director's Interest Notice - PH 3 pages 192.2KB Regulatory Filings	2022-10-30	English
Change in substantial holding - PH 3 pages 231.1KB Regulatory Filings	2022-10-30	English
Notice Under Section 708A 1 page 138.7KB Regulatory Filings	2022-10-26	English
RAD agreement with NorthStar for supply of Actinium-225 3 pages 171.9KB Regulatory Filings	2022-10-25	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.6MB Regulatory Filings	2022-10-25	English
Application for quotation of securities - RAD 6 pages 28.4KB Regulatory Filings	2022-10-25	English
Appendix 2A 21 pages 390.2KB Regulatory Filings	2022-10-24	English
Entitlement Offer - Letter to Eligible Retail Shareholders 3 pages 563.8KB Regulatory Filings	2022-10-24	English
Entitlement Offer - Letter to Option Holders 2 pages 544.4KB Regulatory Filings	2022-10-24	English
Entitlement Offer - Letter to Ineligible Shareholders 3 pages 554.8KB Regulatory Filings	2022-10-24	English
Successful Completion of Institutional Entitlement Offer 9 pages 273.0KB Regulatory Filings	2022-10-19	English
Supplementary Prospectus 7 pages 185.1KB Regulatory Filings	2022-10-19	English
Reinstatement to Quotation 1 page 89.1KB Regulatory Filings	2022-10-19	English
Update - Proposed issue of securities 54 pages 721.5KB Regulatory Filings	2022-10-19	English
Proposed issue of securities - RAD 9 pages 38.9KB Regulatory Filings	2022-10-18	English
Prospectus 57 pages 1.4MB Regulatory Filings	2022-10-18	English
Entitlement Offer to raise up to $10 million 5 pages 240.3KB Regulatory Filings	2022-10-18	English
Entitlement Offer - Presentation 32 pages 2.0MB Regulatory Filings	2022-10-18	English
Update - Proposed issue of securities - RAD 9 pages 38.5KB Regulatory Filings	2022-10-18	English
Pivalate achieves positive Phase 2 data in brain mets trial 2 pages 162.4KB Regulatory Filings	2022-10-17	English
Presentation - Pivalate achieves positive Phase 2 data 8 pages 530.3KB Regulatory Filings	2022-10-17	English
Investor webinar - Pivalate positive Phase 2 data 1 Regulatory Filings	2022-10-17	English
Notice of Annual General Meeting/Proxy Form 42 pages 1.2MB Regulatory Filings	2022-10-16	English
Suspension from Official Quotation 2 pages 128.0KB Regulatory Filings	2022-10-16	English
Trading Halt 2 pages 127.9KB Regulatory Filings	2022-10-12	English
Additional Information - LR4.10.19 1 page 148.3KB Regulatory Filings	2022-10-04	English
NATURE releases encouraging data on role of DUNP19 receptors 2 pages 179.6KB Regulatory Filings	2022-10-03	English
Annual Report to shareholders 84 pages 1.9MB Regulatory Filings	2022-09-29	English
Appendix 4G 12 pages 261.8KB Regulatory Filings	2022-09-29	English
ESG Report 8 pages 685.5KB Regulatory Filings	2022-09-29	English
Corporate Governance Statement 7 pages 190.2KB Regulatory Filings	2022-09-29	English
Ga68-Integrin (RAD301) selected for presentation at EANM 2 pages 145.7KB Regulatory Filings	2022-09-26	English
Pivalate phase II data to be presented at October conference 2 pages 116.6KB Regulatory Filings	2022-09-20	English
RAD and SHINE Supply Agreement for Cancer-Fighting Isotope 2 pages 162.7KB Regulatory Filings	2022-09-19	English
Notification regarding unquoted securities - RAD 8 pages 34.0KB Regulatory Filings	2022-09-19	English
FDA grants rare pediatric disease designation for DUNP19 2 pages 167.9KB Regulatory Filings	2022-09-15	English
FDA grants pediatric disease designation for DUNP19-revised 3 pages 172.1KB Regulatory Filings	2022-09-15	English
JV with MD Anderson to develop novel radiopharmaceuticals 3 pages 196.3KB Regulatory Filings	2022-09-13	English
FDA grants Orphan drug status to RAD DUNP19 for Osteosarcoma 2 pages 163.3KB Regulatory Filings	2022-09-08	English
Appendix 4E and Preliminary Final Report - unaudited 1 Regulatory Filings	2022-09-04	English
Application for quotation of securities - RAD 6 pages 27.3KB Regulatory Filings	2022-08-31	English
Appendix 4E and Preliminary Final Report 46 pages 275.7KB Regulatory Filings	2022-08-30	English
Notification of Release of Shares from Escrow 1 pag Regulatory Filings	2022-08-22	English
Strategic agreements with Lantheus and NanoMab 2 pages 246.7KB Regulatory Filings	2022-08-03	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.6MB Regulatory Filings	2022-07-28	English
GenesisCare agreement extended to prostate cancer trial 2 pages 116.9KB Regulatory Filings	2022-06-30	English
Dr Susann Brady-Kalnay added to Scientific Advisory Board 2 pages 118.3KB Regulatory Filings	2022-06-20	English
Investor webinar - RAD adds brain tumor technology 1 Regulatory Filings	2022-06-14	English
Supply agreement with Isotopia for Lutetium-177 3 pages 210.2KB Regulatory Filings	2022-06-13	English
RAD adds Brain Tumor Technology to Portfolio 3 pages 223.1KB Regulatory Filings	2022-06-08	English
Investor Presentation 15 pages 2.3MB Regulatory Filings	2022-06-08	English
RAD Appoints Dr Leila Alland as Non-Executive Director 2 pages 117.2KB Regulatory Filings	2022-06-05	English
Initial Director's Interest Notice - LA 3 pages 254.1KB Regulatory Filings	2022-06-05	English
Industry leader Vittorio Puppo appointed COO 2 pages 119.2KB Regulatory Filings	2022-05-31	English
Notification regarding unquoted securities - RAD 8 pages 33.5KB Regulatory Filings	2022-05-29	English
Application for quotation of securities - RAD 7 pages 29.2KB Regulatory Filings	2022-05-26	English
Notice Under Section 708A 1 page 177.8KB Regulatory Filings	2022-05-26	English
RAD presentation to Bioshares Biotech Summit 19 pages 2.3MB Regulatory Filings	2022-05-11	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.3MB Regulatory Filings	2022-04-28	English
Virtual investor conference presentation 2 May 2022 1 Regulatory Filings	2022-04-27	English
Change of Director's Interest Notice - PH 3 pages 181.9KB Regulatory Filings	2022-04-13	English
Change of Director's Interest Notice - IT 3 pages 182.3KB Regulatory Filings	2022-04-12	English
Change of Director's Interest Notice - RC 3 pages 180.8KB Regulatory Filings	2022-04-11	English
RAD Licenses UCLA Dual Action Antibody 3 pages 237.3KB Regulatory Filings	2022-04-03	English
RAD Dual Action Antibody Investor Deck 18 pages 2.0MB Regulatory Filings	2022-04-03	English
Change of Director's Interest Notice - HL 3 pages 181.4KB Regulatory Filings	2022-03-30	English
Investor Presentation 13 pages 1.0MB Regulatory Filings	2022-03-27	English
LOI with GenesisCare to start first trial in Australia 2 pages 144.4KB Regulatory Filings	2022-03-22	English
Change of Director's Interest Notice - IT 3 pages 162.5KB Regulatory Filings	2022-03-03	English
Half Yearly Report and Accounts 33 pages 1.5MB Regulatory Filings	2022-02-27	English
Change in substantial holding NT 3 pages 429.9KB Regulatory Filings	2022-02-24	English
Radiopharm and Terrapower supplementary announcement 2 pages 137.2KB Regulatory Filings	2022-02-09	English
Initial Director's Interest Notice - HL 3 pages 254.5KB Regulatory Filings	2022-02-03	English
Director Appointment/Resignation 2 pages 178.9KB Regulatory Filings	2022-02-01	English
Hester Larkin appointed as Non-Executive Director 2 pages 178.9KB Regulatory Filings	2022-02-01	English
Radiopharm and TerraPower sign Actinium 225 agreement 2 pages 195.0KB Regulatory Filings	2022-01-31	English
Application for quotation of securities - RAD 6 pages 27.7KB Regulatory Filings	2022-01-26	English
Proposed issue of securities - RAD 5 pages 27.5KB Regulatory Filings	2022-01-24	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.2MB Regulatory Filings	2022-01-24	English
RAD acquires IP Ownership of Radiopharmaceutical Nanobodies 2 pages 172.0KB Regulatory Filings	2022-01-23	English
Change of Director's Interest Notice - RC 3 pages 205.8KB Regulatory Filings	2022-01-10	English
RAD to present at Biotech Showcase 1 page 114.3KB Regulatory Filings	2022-01-09	English